Psychedelic Alpha: MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics
Today’s announcement perhaps reflects something of an eggshell-treading transition: Lykos has dropped “MAPS” from its name, but perhaps retains a nod to its founder and its nonconformist roots; it’s …